Dados B3 › CEPE5
CEPE5 (Celpe): has profit grown?
CEPE5 (Celpe): in 2025, net income was R$ 659.0 million, up 601% versus 2024 (a profit of R$ 94.0 million); five years earlier (2020), a profit of R$ 217.0 million.
| Year | Profit (loss) | Change |
|---|---|---|
| 2025 | R$ 659.0 million | up 601% |
| 2024 | R$ 94.0 million | up 1,467% |
| 2023 | R$ 6.0 million | down 96% |
| 2022 | R$ 157.0 million | down 58% |
| 2021 | R$ 376.0 million | up 73% |
| 2020 | R$ 217.0 million | up 119,577% |
| 2019 | R$ 181,322.00 | down 100% |
| 2018 | R$ 111.9 million | up 98% |
| 2017 | R$ 56.4 million | a turn from loss to profit |
| 2016 | -R$ 333,000.00 | — |
Annual statements (DFP). Profit attributable to controlling shareholders when the company reports it; otherwise total net income. Fact with its source; not investment advice.
Check it yourself
- Open data, no key needed for WEGE3 and with a free key for any company:
https://dadosb3.com/empresas/CEPE5/fatos - Every annual figure comes from the DFP filed with the CVM (dados.cvm.gov.br); dividends come from B3.
- The company page shows the account each number came from: CEPE5.
Dividends · Debt · Full page · How much it returned · plain text for AI
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:08 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:08 UTC. If this does not match /saude, you are reading a cached copy.